Sedation, Analgesia and Neuromuscular Blockade
Sedation, analgesia and neuromuscular blockade are the pharmacological tools used to keep critically ill patients comfortable, safe and synchronous with life-supporting therapies such as mechanical ventilation. Contemporary critical care frames them together because pain, agitation, sedation depth and delirium are interlinked, and because the goals have shifted from deep, immobilising sedation toward analgesia-first, lightly sedated, interactive patients.
Definition
The management of pain, agitation/sedation, delirium and — where indicated — skeletal-muscle paralysis in critically ill patients, integrated as a single bundle of assessment and intervention often summarised by the pain-agitation/sedation-delirium-immobility-sleep (PADIS) framework.
Scope
This area orients the reader to the agents and assessment tools that govern comfort and consciousness in the intensive care unit: sedatives, analgesics, neuromuscular blocking agents, the syndrome of ICU delirium, and the validated scales used to measure pain, sedation depth and delirium. It treats these as reference topics within critical care medicine and is not a source of dosing or bedside management instructions.
Sub-topics
Key concepts
- Analgesia-first (analgosedation) strategy
- Light versus deep sedation
- Pain, agitation/sedation and delirium as linked targets
- Validated assessment scales (pain, sedation, delirium)
- Daily sedation interruption and spontaneous awakening trials
- Neuromuscular blockade as a distinct, paralysing intervention
- The ABCDEF / ICU Liberation bundle
Clinical relevance
How sedation, analgesia and paralysis are delivered shapes ventilator time, delirium burden and long-term cognitive and functional outcomes, which is why these topics anchor modern critical care practice. The PADIS guidelines and the ABCDEF bundle describe an evidence-based system of assessment and management; this entry summarises that framework for orientation and is not a protocol for treating an individual patient.
Epidemiology
Most mechanically ventilated ICU patients receive sedatives and analgesics, and a large proportion experience delirium at some point during critical illness; deep early sedation and benzodiazepine exposure are associated with worse outcomes, motivating the move to lighter, analgesia-based approaches.
Evidence & guidelines
The 2018 Society of Critical Care Medicine PADIS guidelines (Devlin et al.) are the principal reference, integrating recommendations across pain, agitation/sedation, delirium, immobility and sleep. Implementation is operationalised through the ABCDEF bundle, whose large-scale evaluation (Pun et al., 2019) linked bundle adherence to better survival and less delirium; trials such as Strøm et al. (2010) further showed that lighter or minimal sedation strategies are feasible.
History
Through the late twentieth century, critically ill patients were often deeply sedated and immobilised. Recognition that prolonged deep sedation and benzodiazepines prolonged ventilation and worsened cognition drove a shift, consolidated in successive SCCM guidelines (2002, 2013, and the 2018 PADIS update), toward analgesia-first, light, interactive sedation and toward systematically assessing and preventing delirium.
Key figures
- John Devlin
- E. Wesley Ely
- Pratik Pandharipande
- Brenda Pun
Related topics
Seminal works
- devlin-2018
- pun-2019
- strom-2010
Frequently asked questions
- Why are sedation, analgesia and neuromuscular blockade discussed together?
- They jointly determine a critically ill patient's comfort and level of consciousness, and modern practice manages pain, sedation depth and delirium as an integrated bundle because choices in one domain affect the others.
- What is the 'analgesia-first' idea?
- It is the principle of treating pain before adding sedatives and keeping sedation as light as the patient's condition allows, because deep sedation and benzodiazepine use are associated with longer ventilation and more delirium.